Chemomab Therapeutics Ltd. (CMMB) SEC Filings & Financial Intelligence
Chemomab Therapeutics Ltd. (CMMB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CMMB
CIK: 1534248
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Somekh Chaikin
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerSarit Nethanel
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-30 | 2026-09-30 | 6-K | 0001178913-26-004676 | View SEC Doc Filr Page |
| S-4 | 2026-09-25 | — | S-4 | 0001493152-26-044397 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-09 | — | SCHEDULE 13D/A Filing | 0001104659-26-106301 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-27 | 4 Filing | 0001178913-26-004371 | View SEC Doc Filr Page |
| 6-K | 2026-08-19 | 2026-06-30 | 6-K | 0001178913-26-004193 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0002148623-26-000001 | View SEC Doc Filr Page |
| DRS | 2026-08-12 | — | DRS Filing | 0001493152-26-037222 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-10 | — | SCHEDULE 13G/A Filing | 0001995601-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-07-16 | — | SCHEDULE 13D Filing | 0001104659-26-084244 | View SEC Doc Filr Page |
| 6-K | 2026-07-08 | 2026-07-08 | 6-K | 0001178913-26-003442 | View SEC Doc Filr Page |
| 3 | 2026-06-03 | 2026-06-01 | FORM 3 | 0001178913-26-003083 | View SEC Doc Filr Page |
| 6-K | 2026-06-02 | 2026-06-02 | 6-K | 0001178913-26-003058 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-29 | 4 Filing | 0001178913-26-003004 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2026-05-14 | 6-K | 0001178913-26-002672 | View SEC Doc Filr Page |
| 6-K | 2026-05-06 | 2026-05-06 | 6-K | 0001178913-26-002423 | View SEC Doc Filr Page |
| 6-K | 2026-04-28 | 2026-04-28 | 6-K | 0001178913-26-002274 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-03-18 | 3 Filing | 0001178913-26-002070 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-03-18 | FORM 3 | 0001178913-26-002068 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-03-18 | 3 Filing | 0001178913-26-002066 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-03-18 | 3 Filing | 0001178913-26-002064 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-03-18 | 3 Filing | 0001178913-26-002062 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-03-18 | 3 Filing | 0001178913-26-002060 | View SEC Doc Filr Page |
| 3 | 2026-03-31 | 2026-03-18 | 3 Filing | 0001178913-26-001962 | View SEC Doc Filr Page |
| 3 | 2026-03-31 | 2026-03-18 | 3 Filing | 0001178913-26-001960 | View SEC Doc Filr Page |
| 20-F | 2026-03-23 | 2025-12-31 | 20-F | 0001178913-26-001593 | View SEC Doc Filr Page |